Brief: CSPC Pharmaceutical Group Declares Interim Dividend Of HK18 Cents Per Share
20/08/2026 05:20
BRIEF-CSPC Pharmaceutical Group Declares Interim Dividend Of HK18 Cents Per Share Aug 20 (Reuters) - CSPC Pharmaceutical Group - interim dividend of HK18 cents per share for 2026.
- H1 net income attributable RMB 6,094.2 million
- H1 revenue RMB 18,594.5 million
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines